Standard Biotools Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Standard Biotools Inc 's inventory turnover ratio, the ratio that measures Standard Biotools Inc 's ability to manage its supply chain, sequentially decreased to 1.36 in the first quarter 2026, which does not come as a surprise, as the Standard Biotools Inc continue to experience headwinds, which also impact its supply chain. Standard Biotools Inc 's average inventory processing period in the Mar 31 2026 quarter, has increased to 268 days, from 243 days, in the Dec 31 2025 quarter.

Within Healthcare sector 276 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1389 in the fourth quarter 2025, to 1482.

LAB Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Standard Biotools Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

LAB Inventory Turnover Ratio	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Inventory Growth	-55.86 %	-50.95 %	-40.39 %	-43.29 %	4.38 %
Y / Y Cost of Sales Growth	-57.14 %	-	-52.38 %	-50 %	0 %
Inventory Turnover Ratio (TTM)	1.36	-	2.05	2.11	2.14
LAB's Total Ranking	# 1482	# 1389	# 968	# 1259	# 1450
Average inventory processing period	268	-	178	173	170
Seq. Inventory Growth	-6.94 %	-21.39 %	5.16 %	-42.62 %	3.41 %
Seq. Cost of Sales Growth	-	-	-9.09 %	-47.62 %	-19.23 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Laboratory Analytical Instruments Industry	# 19
Healthcare Sector	# 277
Overall Market	# 1482

Inventory Turnover Ratio Statistics
High	Average	Low
5.34	2.22	0.24
(Sep 30 2019)		(Jun 30 2017)

LAB Company Profile >> Back to LAB Efficiency Comparisons >> Compare LAB Inventory Turnover Ratio to its Competitors

Financial Statements
Standard Biotools Inc 's Inventories	$ 19 Millions	Visit LAB's Balance sheet
Standard Biotools Inc 's Cost of Revenues TTM	$ 30 Millions	Visit LAB's Income Statement
What are LAB's Sales?		Visit LAB's Sales by Segment

Other Inventory Turnover Ratios
Standard Biotools Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Laboratory Analytical Instruments Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
LAB's Inventory Turnover Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for LAB's Competitors
Inventory Turnover Ratio for LAB's Suppliers
Inventory Turnover Ratio for LAB's Customers

You may also want to know
LAB's Sales Growth Rates	LAB's Pe Price to earnings ratio	LAB's Receivables Turnover Ratio	LAB's Stock Quote
LAB's Net Income Growth Rates	LAB's Ps Price to Sales ratio	LAB's Sales per Employee	LAB's Asset Turnover Ratio
LAB's Net Margin	LAB's Pb Price to Book ratio	LAB's Financial Strength Ratios	LAB's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Mar 31 2026	Inventories at quarter ending Mar 31 2026
Guardant Health Inc	4.41	$ 379.203 Millions	$ 86 Millions
Idexx Laboratories Inc	4.38	$ 1,690.942 Millions	$ 386 Millions
Envista Holdings Corporation	4.36	$ 1,267.000 Millions	$ 290 Millions
Inotiv Inc	4.25	$ 175.895 Millions	$ 41 Millions
Cryoport inc	4.23	$ 96.609 Millions	$ 23 Millions
Teva Pharmaceutical Industries Limited	4.22	$ 8,317.000 Millions	$ 1,971 Millions
Incyte Corporation	4.21	$ 403.465 Millions	$ 96 Millions
Electromed Inc	4.16	$ 14.195 Millions	$ 3 Millions
Vericel Corporation	4.15	$ 73.494 Millions	$ 18 Millions
Sharps Technology Inc	4.12	$ 3.585 Millions	$ 1 Millions
Coherus Oncology inc	4.11	$ 14.975 Millions	$ 4 Millions
Novocure Limited	4.08	$ 167.287 Millions	$ 41 Millions
Lifeward ltd	4.08	$ 13.275 Millions	$ 3 Millions
Ge Healthcare Technologies Inc	4.04	$ 9,262.000 Millions	$ 2,294 Millions
Koru Medical Systems Inc	3.99	$ 16.468 Millions	$ 4 Millions
3m Company	3.94	$ 15,087.000 Millions	$ 3,830 Millions
Iridex Corp	3.92	$ 32.247 Millions	$ 8 Millions
Myomo Inc	3.88	$ 14.000 Millions	$ 4 Millions
Escalon Medical Corp	3.79	$ 6.698 Millions	$ 2 Millions
Evolus Inc	3.71	$ 103.000 Millions	$ 28 Millions
Abbvie Inc	3.70	$ 18,420.000 Millions	$ 4,975 Millions
Alpha Teknova Inc	3.69	$ 26.248 Millions	$ 7 Millions
Biocryst Pharmaceuticals Inc	3.67	$ 19.884 Millions	$ 5 Millions
Neuraxis Inc	3.61	$ 0.665 Millions	$ 0 Millions
Mirum Pharmaceuticals Inc	3.50	$ 85.221 Millions	$ 24 Millions
Elite Pharmaceuticals Inc	3.43	$ 71.976 Millions	$ 21 Millions
Tandem Diabetes Care Inc	3.42	$ 457.823 Millions	$ 134 Millions
Exelixis Inc	3.41	$ 84.478 Millions	$ 25 Millions
Baxter International Inc	3.37	$ 7,911.000 Millions	$ 2,348 Millions
Gilead Sciences Inc	3.36	$ 6,139.000 Millions	$ 1,825 Millions

Date modified: 2026-08-29T17:24:28+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.